Basel, Switzerland

Marija Plodinec

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Marija Plodinec: Innovator in Breast Cancer Research**

Introduction

Marija Plodinec is a distinguished inventor based in Basel, Switzerland, recognized for her contributions to the field of breast cancer research. With a total of five patents to her name, she has focused on innovative methods for classifying cancerous tissue samples, aiding in the advancement of personalized medicine.

Latest Patents

Marija's latest patent addresses a crucial challenge in oncology: the classification of breast cancer molecular subtypes through a technique known as nanomechanical profiling. This invention involves measuring the stiffness of various points on tissue samples obtained from mammary carcinoma. By analyzing the stiffness distribution, the method enables the assignment of the sample to specific breast cancer subtypes and nodal status, thereby improving the precision of cancer diagnosis and treatment options.

Career Highlights

Throughout her career, Marija has been associated with prominent institutions such as the University of Basel. Her research work demonstrates a strong commitment to leveraging innovative techniques in the fight against cancer. Her pioneering efforts in nanomechanical profiling contribute significantly to the understanding of tumor mechanics and its implications for breast cancer treatment.

Collaborations

Marija has collaborated with esteemed colleagues including Marko Loparic and Roderick Lim, which has further enriched her research initiatives. Their teamwork reflects the collaborative spirit prevalent in research institutions, fostering an environment where groundbreaking discoveries can thrive.

Conclusion

Marija Plodinec stands as a testament to the impact that dedicated inventors can have in the medical field. Her innovative patents and collaborative efforts underscore the potential for advancements in cancer treatment through novel methodologies. As she continues her work in Basel, the scientific community eagerly anticipates the future contributions she will make towards improving patient outcomes in breast cancer care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…